Europe Diabetes Care Devices Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Oct 2019
  • Europe
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Europe Diabetes Care Devices Market By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Institutional Sales, Retail Sales), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe) - Industry Trends and Forecast to 2026

Market Analysis: Europe Diabetes Care Devices Market

Europe diabetes care devices market is registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to the increases incidence for patients with diabetes and development of the need for a quicker, healthier and effective method of diagnosing and treating diabetes.

Market Definition: Europe Diabetes Care Devices Market

Diabetes is a disorder that cannot produce the insulin produced in the serum in the pancreas. Increased blood sugar induces untreated diabetes. Diabetes treatments are used for diabetes diagnosis in particular. Treatment strategies for diabetes are used to stimulate glucose in the body. It is used primarily for the analysis for glucose levels in the body. Blood glucose meters and strips are used to track glucose levels. Diabetes care devices are small in size and also compact.

Market Drivers

  • Increases incidence for patients with diabetes is driving the growth of the market
  • Development of diabetes technology is propelling the growth of the market
  • Raising awareness of diabetes care devices is boosting the growth of the market
  • Development of the need for a quicker, healthier and effective method of diagnosing and treating diabetes is contributing to the growth of the market

Market Restraints

  • Lack of compensation or strict rules is hampering the growth of the market
  • Low expenditure per person on diabetes is hindering the growth of the market
  • Consequences Associated to Insulin delivery devices is restricting the growth of the market

Segmentation: Europe Diabetes Care Devices Market

By Product

  • Blood Glucose Monitoring Devices

    • Testing Strips
    • Blood Glucose Meters

      • Self-monitoring Blood Glucose Meters
      • Continuous Blood Glucose Monitoring Devices

    • Lancets
    • Others

  • Insulin Delivery Devices

    • Insulin Syringes
    • Insulin Pens
    • Insulin Pumps
    • Insulin Jet Injectors
    • Others

By Distribution Channel

  • Institutional Sales

    • Hospitals
    • Clinics
    • Others

  • Retail Sales

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

By Country

  • Germany
  • Italy
  • U.K.
  • France
  • Spain
  • Netherlands
  • Belgium
  • Switzerland
  • Turkey
  • Russia
  • Rest of Europe

Key Developments in the Market:

  • In August 2019, Nemaura Medical, a medical technology corporation based on the commercialization of SugarBEAT as a non-invasive, inexpensive and portable Continuous Glucose Monitor (CGM) for diabetic and pre-diabetic usage, today announced the first delivery of SugarBEAT for diabetic and pre-diabetic patients in the United Kingdom. Such deliveries were part of the first step of Nemaura Medical's SugarBEAT roll-out plan following the recent authorization of the CE label in Europe.
  • In July 2019, Biocorp, a French medical device company, recently received $4.5 million to further improve and incorporate the Mallya Insulin Pen Smart Cap into Sanofi's Unified Diabetes Care system, notes Close Concerns. The news came soon after Biocorp confirmed that Mallya had earned the CE mark as a category IIb medical device, rendering it the only company with this new regulatory classification. This thrilling first step towards a relationship with Sanofi, one of the three biggest diabetes care organizations, reinforces their place as the world leader in connected devices.

Competitive Analysis:

Europe diabetes care devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of diabetes care devices for Europe.

Key Market Competitors:

Few of the major market competitors currently working in the Europe diabetes care devices market are Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Dexcom, Inc., Medtronic, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation., Medisana GmbH, Trividia Health, Inc., Rossmax International Ltd., Crownpeak Technology, Inc., Novo Nordisk A/S, Sanofi, among others.

Research Methodology:  Europe Diabetes Care Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Europe diabetes care devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19